X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (257) 257
Publication (36) 36
Book Chapter (7) 7
Conference Proceeding (4) 4
Book Review (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (160) 160
genetics & heredity (113) 113
female (96) 96
male (86) 86
index medicus (81) 81
mutation (53) 53
adult (44) 44
child (41) 41
neurofibromatosis (40) 40
adolescent (39) 39
neurofibromatosis 1 - genetics (35) 35
middle aged (32) 32
phenotype (31) 31
neurofibromatosis type 1 (29) 29
child, preschool (27) 27
genetic aspects (25) 25
tumors (25) 25
genetics (24) 24
gene (23) 23
research (23) 23
nf1 (22) 22
animals (21) 21
identification (21) 21
article (20) 20
mutations (20) 20
syndrome (20) 20
biochemistry & molecular biology (19) 19
genes, neurofibromatosis 1 (19) 19
oncology (19) 19
dna mutational analysis (18) 18
pedigree (18) 18
diagnosis (17) 17
neurofibromatosis 1 - complications (17) 17
aged (16) 16
children (16) 16
gene deletion (16) 16
molecular sequence data (16) 16
base sequence (15) 15
mice (15) 15
cancer (14) 14
infant (14) 14
mosaicism (14) 14
neurofibromatosis type-1 (14) 14
neurofibromin 1 - genetics (14) 14
proteins (14) 14
pediatrics (13) 13
young adult (13) 13
noonan syndrome (12) 12
alleles (11) 11
analysis (11) 11
congenital, hereditary, and neonatal diseases and abnormalities (11) 11
exons (11) 11
gene mutations (11) 11
membrane proteins - genetics (11) 11
noonan syndrome - genetics (11) 11
risk factors (11) 11
vonrecklinghausen neurofibromatosis (11) 11
chromosomes (10) 10
genes (10) 10
genetic disorders (10) 10
in situ hybridization, fluorescence (10) 10
neurofibromatosis 1 - diagnosis (10) 10
nf1 gene (10) 10
ovarian neoplasms - genetics (10) 10
polymerase chain reaction (10) 10
recklinghausen's disease (10) 10
sequence deletion (10) 10
signal transduction (10) 10
autism (9) 9
belgium (9) 9
genetic predisposition to disease (9) 9
genomics (9) 9
intracellular signaling peptides and proteins - genetics (9) 9
legius syndrome (9) 9
mutation - genetics (9) 9
obstetrics & gynecology (9) 9
pathway (9) 9
patients (9) 9
abridged index medicus (8) 8
chromosome aberrations (8) 8
chromosome deletion (8) 8
comparative genomic hybridization (8) 8
deletions (8) 8
disease (8) 8
genetic testing (8) 8
genotype & phenotype (8) 8
locus (8) 8
medical genetics (8) 8
mutation, missense (8) 8
nervous system diseases (8) 8
neurofibromatosis 1 - metabolism (8) 8
neurofibromatosis 1 - pathology (8) 8
population (8) 8
pregnancy (8) 8
abnormalities, multiple - genetics (7) 7
amino acid sequence (7) 7
aneuploidy (7) 7
cafe-au-lait spots - genetics (7) 7
expression (7) 7
family (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 2014, Volume 514, Issue 7521, pp. 247 - 251
The polycomb repressive complex 2 (PRC2) exerts oncogenic effects in many tumour types(1). However, loss-of-function mutations in PRC2 components occur in a... 
SUPPRESSOR | GENE | MULTIDISCIPLINARY SCIENCES | MICE | NF1 MICRODELETION PATIENTS | MUTATIONS | BET BROMODOMAIN INHIBITION | CANCER | TUMORS | NEUROFIBROMATOSIS TYPE-1 | EZH2 | Chromatin - metabolism | Transcription, Genetic - drug effects | Polycomb Repressive Complex 2 - genetics | Humans | Transcription Factors - deficiency | ras Proteins - metabolism | Neurofibromin 1 - deficiency | Glioma - genetics | Neoplasms - genetics | Melanoma - genetics | Tumor Suppressor Proteins - deficiency | Glioma - pathology | Nerve Sheath Neoplasms - pathology | Nuclear Proteins - deficiency | Tumor Suppressor Proteins - genetics | Epigenesis, Genetic - drug effects | Cell Death - drug effects | Gene Expression Regulation, Neoplastic - drug effects | Nuclear Proteins - genetics | Chromatin - drug effects | Nerve Sheath Neoplasms - drug therapy | Disease Models, Animal | Triazoles - therapeutic use | Nerve Sheath Neoplasms - genetics | Tumor Suppressor Proteins - metabolism | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | ras Proteins - antagonists & inhibitors | Nuclear Proteins - metabolism | Transcription Factors - antagonists & inhibitors | Melanoma - pathology | Transcription Factors - genetics | Azepines - therapeutic use | Neoplasms - drug therapy | Azepines - pharmacology | Transcription Factors - metabolism | Triazoles - pharmacology | Animals | Polycomb Repressive Complex 2 - deficiency | Melanoma - drug therapy | Nuclear Proteins - antagonists & inhibitors | Mice | Neoplasms - pathology | Polycomb Repressive Complex 2 - metabolism | Chromatin - genetics | Neurofibromin 1 - genetics | Glioma - drug therapy | Epigenetic inheritance | Ras genes | Genetic transcription | Research | Gliomas | Studies | Mutation | Genes | Tumors | Defects
Journal Article
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2016, Volume 140, Issue 2, pp. 543 - 552.e5
Journal Article
Journal Article
Journal Article